Adenovirus-Mediated Transfer of the Acid -Glucosidase Gene into Fibroblasts, Myoblasts and Myotubes from Patients with Glycogen Storage Disease Type II Leads to High Level Expression of Enzyme and Corrects Glycogen Accumulation
- 1 October 1998
- journal article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 7 (11) , 1695-1702
- https://doi.org/10.1093/hmg/7.11.1695
Abstract
Glycogen storage disease type II (GSD II) is an autosomal recessive disorder caused by defects in the lysosomal acid α-glucosidase (GAA) gene. We investigated the feasibility of using a recombinant adenovirus containing the human GAA gene under the control of the cytomegalovirus promoter (AdCMV-GAA) to correct the enzyme deficiency in different cultured cells from patients with the infantile form of GSD II. In GAA-deficient fibroblasts infected with AdCMV-GAA, transduction and transcription of the human transgene resulted in de novo synthesis of GAA protein. The GAA enzyme activity was corrected from the deficient level to 12 times the activity of normal cells. The transduced cells overexpressed the 110 kDa precursor form of GAA, which was secreted into the culture medium and was taken up by recipient cells. The recombinant GAA protein was correctly processed and was active on both an artificial substrate 4-methylumbelliferyl-α-D-glucopyranoside (4MUG) and glycogen. In GAA-deficient muscle cells, a significant increase in cellular enzyme level, ∼20-fold higher than in normal cells, was also observed after viral treatment. The transduced muscle cells were also able to efficiently secrete the recombinant GAA. Moreover, transfer of the human transgene resulted in normalization of cellular glycogen content with clearance of glycogen from lysosomes, as assessed by electron microscopy, in differentiated myotubes. These results demonstrate phenotypic correction of cultured skeletal muscle from a patient with infantile-onset GSD II using a recombinant adenovirus. We conclude that adenovirus-mediated gene transfer might be a suitable model system for further in vivo studies on delivering GAA to GSD II muscle, not only by direct cell targeting but also by a combination of secretion and uptake mechanisms.Keywords
This publication has 20 references indexed in Scilit:
- Safe gene vectors made simplerNature Biotechnology, 1997
- Isolation and Characterisation of a Recombinant, Precursor form of Lysosomal Acid α‐GlucosidaseEuropean Journal of Biochemistry, 1995
- Glycogenosis type II (acid maltase deficiency)Muscle & Nerve, 1995
- Erythropoietin Gene Transfer and Expression in Adult Normal Mice: Use of an Adenovirus VectorHuman Gene Therapy, 1994
- Widespread long-term gene transfer to mouse skeletal muscles and heart.Journal of Clinical Investigation, 1992
- Isolation and Partial Characterization of the Structural Gene for Human Acid Alpha GlucosidaseDNA and Cell Biology, 1991
- Sequence of the cDNA and 5′-Flanking Region for Human Acid α-Glucosidase, Detection of an Intron in the 5′ Untranslated Leader Sequence, Definition of 18-bp Polymorphisms, and Differences with Previous cDNA and Amino Acid SequencesDNA and Cell Biology, 1990
- Transport and processing of endocytosed lysosomal alpha-glucosidase in cultured human skin fibroblastsEuropean Journal of Biochemistry, 1986
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977
- Improved Technique for Electron Microscopy of Cultured CellsStain Technology, 1977